Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension

Angiogenesis

Volumn 14, Issue 1, 2011, Pages 17-27

  Smadja, David M ^a,b,d   Mauge, Laetitia ^a,b   Gaussem, Pascale ^a,b   D'Audigier, Clément ^a,b   Israel Biet, Dominique ^a,c   Celermajer, David S ^e   Bonnet, Damien ^a,f   Lévy, Marilyne ^a,f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Congenital heart disease; EPC; Pulmonary hypertension; Treprostinil; Vasodilator treatment

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; MATRIGEL; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; UNIPROST;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CD34 SELECTION; CHILD; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WOUND HEALING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CELL COUNT; CELL SEPARATION; CHILD; COLONY-FORMING UNITS ASSAY; ENDOTHELIAL CELLS; EPOPROSTENOL; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERTENSION, PULMONARY; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

MUS MUSCULUS;

EID: 79952280259     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-010-9192-y     Document Type: Article

References (49)

1. G Simonneau IM Robbins M Beghetti RN Channick M Delcroix CP Denton CG Elliott SP Gaine MT Gladwin ZC Jing MJ Krowka D Langleben N Nakanishi R Souza 2009 Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43 S54 10.1016/j.jacc.2009.04.012 19555858
2. M Izikki C Guignabert E Fadel M Humbert L Tu P Zadigue P Dartevelle G Simonneau S Adnot B Maitre B Raffestin S Eddahibi 2009 Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents J Clin Invest 119 512 523 1:CAS:528:DC%2BD1MXivF2kt7g%3D 10.1172/JCI35070 19197140
3. M Humbert D Montani F Perros P Dorfmuller S Adnot S Eddahibi 2008 Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension Vascul Pharmacol 49 113 118 1:CAS:528:DC%2BD1cXhtlGhtLbM 10.1016/j.vph.2008.06.003 18606248
4. M Levy C Maurey DS Celermajer PR Vouhe C Danel D Bonnet D Israel-Biet 2007 Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease J Am Coll Cardiol 49 803 810 1:CAS:528: DC%2BD2sXhvVyhsbc%3D 10.1016/j.jacc.2006.09.049 17306711 (Pubitemid 46240714)
5. DP Sieveking A Buckle DS Celermajer MK Ng 2008 Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay J Am Coll Cardiol 51 660 668 1:CAS:528:DC%2BD1cXhslGrtbw%3D 10.1016/j.jacc.2007.09.059 18261686 (Pubitemid 351186872)
6. DM Smadja I Bieche JS Silvestre S Germain A Cornet I Laurendeau JP Duong-Van-Huyen J Emmerich M Vidaud M Aiach P Gaussem 2008 Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis Arterioscler Thromb Vasc Biol 28 2137 2143 1:CAS:528:DC%2BD1cXhtlKrtrzO 10.1161/ATVBAHA.108.168815 18818419
7. MC Yoder LE Mead D Prater TR Krier KN Mroueh F Li R Krasich CJ Temm JT Prchal DA Ingram 2007 Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109 1801 1809 1:CAS:528:DC%2BD2sXjtFeqtrc%3D 10.1182/blood-2006-08-043471 17053059 (Pubitemid 46348173)
8. K Asosingh MA Aldred A Vasanji J Drazba J Sharp C Farver SA Comhair W Xu L Licina L Huang B Anand-Apte MC Yoder RM Tuder SC Erzurum 2008 Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension Am J Pathol 172 615 627 1:CAS:528:DC%2BD1cXktVKhtbY%3D 10.2353/ajpath.2008.070705 18258847 (Pubitemid 351354535)
9. Z Junhui W Xingxiang F Guosheng S Yunpeng Z Furong C Junzhu 2008 Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension Respir Med 102 1073 1079 10.1016/j.rmed.2007.12.030 18394873
10. GP Diller S van Eijl DO Okonko LS Howard O Ali T Thum SJ Wort E Bedard JS Gibbs J Bauersachs AJ Hobbs MR Wilkins MA Gatzoulis J Wharton 2008 Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension Circulation 117 3020 3030 1:CAS:528:DC%2BD1cXmsFymu7o%3D 10.1161/CIRCULATIONAHA.108.769646 18519847
11. Smadja DM, Mauge L, Sanchez O, Silvestre JS, Guerin C, Godier A, Henno P, Gaussem P, Israel-Biet D (2010) Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur Respir J (in press)
12. J Hur CH Yoon HS Kim JH Choi HJ Kang KK Hwang BH Oh MM Lee YB Park 2004 Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis Arterioscler Thromb Vasc Biol 24 288 293 1:CAS:528:DC%2BD2cXnsFCgsQ%3D%3D 10.1161/01.ATV.0000114236.77009.06 14699017 (Pubitemid 38197580)
13. JM Hill G Zalos JP Halcox WH Schenke MA Waclawiw AA Quyyumi T Finkel 2003 Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
14. DA Ingram LE Mead H Tanaka V Meade A Fenoglio K Mortell K Pollok MJ Ferkowicz D Gilley MC Yoder 2004 Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood 104 2752 2760 1:CAS:528:DC%2BD2cXpslKjtrg%3D 10.1182/blood-2004-04-1396 15226175 (Pubitemid 39434958)
15. N Nagaya K Kangawa M Kanda M Uematsu T Horio N Fukuyama J Hino M Harada-Shiba H Okumura Y Tabata N Mochizuki Y Chiba K Nishioka K Miyatake T Asahara H Hara H Mori 2003 Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells Circulation 108 889 895 1:CAS:528:DC%2BD3sXmtFCisbo%3D 10.1161/01.CIR.0000079161.56080.22 12835224 (Pubitemid 37022134)
16. YD Zhao DW Courtman Y Deng L Kugathasan Q Zhang DJ Stewart 2005 Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease Circ Res 96 442 450 1:CAS:528: DC%2BD2MXhs12isLk%3D 10.1161/01.RES.0000157672.70560.7b 15692087 (Pubitemid 40354538)
17. XX Wang FR Zhang YP Shang JH Zhu XD Xie QM Tao JZ Chen 2007 Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial J Am Coll Cardiol 49 1566 1571 1:CAS:528:DC%2BD2sXjvFGgtLo%3D 10.1016/j.jacc.2006.12.037 17418297 (Pubitemid 46517955)
18. JH Zhu XX Wang FR Zhang YP Shang QM Tao JH Zhu JZ Chen 2008 Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study Pediatr Transplant 12 650 655 10.1111/j.1399-3046.2007.00863.x 18466198
19. N Galie MM Hoeper M Humbert A Torbicki JL Vachiery JA Barbera M Beghetti P Corris S Gaine JS Gibbs MA Gomez-Sanchez G Jondeau W Klepetko C Opitz A Peacock L Rubin M Zellweger G Simonneau 2009 Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 1219 1263 1:STN:280:DC%2BD1MjpvFKgtA%3D%3D 10.1183/09031936.00139009 19749199
20. N Galie MM Hoeper M Humbert A Torbicki JL Vachiery JA Barbera M Beghetti P Corris S Gaine JS Gibbs MA Gomez-Sanchez G Jondeau W Klepetko C Opitz A Peacock L Rubin M Zellweger G Simonneau A Vahanian A Auricchio J Bax C Ceconi V Dean G Filippatos C Funck-Brentano R Hobbs P Kearney T McDonagh K McGregor BA Popescu Z Reiner U Sechtem PA Sirnes M Tendera P Vardas P Widimsky U Sechtem N Al Attar F Andreotti M Aschermann R Asteggiano R Benza R Berger D Bonnet M Delcroix L Howard AN Kitsiou I Lang A Maggioni JE Nielsen-Kudsk M Park P Perrone-Filardi S Price MT Domenech A Vonk-Noordegraaf JL Zamorano 2009 Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2493 2537 10.1093/eurheartj/ehp297 19713419
21. L Dewachter S Adnot C Guignabert L Tu E Marcos E Fadel M Humbert P Dartevelle G Simonneau R Naeije S Eddahibi 2009 Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension Eur Respir J 34 1100 1110 1:CAS:528:DC%2BD1MXhsFahsb%2FI 10.1183/09031936.00183008 19324947
22. M Toshner R Voswinckel M Southwood R Al-Lamki LS Howard D Marchesan J Yang J Suntharalingam E Soon A Exley S Stewart M Hecker Z Zhu U Gehling W Seeger J Pepke-Zaba NW Morrell 2009 Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension Am J Respir Crit Care Med 180 780 787 10.1164/rccm.200810-1662OC 19628780
23. K Teichert-Kuliszewska MJ Kutryk MA Kuliszewski G Karoubi DW Courtman L Zucco J Granton DJ Stewart 2006 Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension Circ Res 98 209 217 1:CAS:528:DC%2BD28Xnt1CqsA%3D%3D 10.1161/01.RES.0000200180.01710. e6 16357305
24. DM Smadja I Bieche S Susen L Mauge I Laurendeau C d'Audigier F Grelac J Emmerich M Aiach P Gaussem 2009 Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells J Cell Mol Med 13 2534 2546 10.1111/j.1582-4934.2008.00429.x 18657231
25. DM Smadja I Bieche D Helley I Laurendeau G Simonin L Muller M Aiach P Gaussem 2007 Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) J Cell Mol Med 11 1149 1161 1:CAS:528:DC%2BD2sXhsVGrtb3P 10.1111/j.1582-4934.2007.00090.x 17979890 (Pubitemid 350037056)
26. DM Smadja I Bieche G Uzan H Bompais L Muller C Boisson-Vidal M Vidaud M Aiach P Gaussem 2005 PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system Arterioscler Thromb Vasc Biol 25 2321 2327 1:CAS:528:DC%2BD2MXhtFCisbbL 10.1161/01.ATV.0000184762.63888.bd 16141404 (Pubitemid 41552649)
27. Smadja DM, d'Audigier C, Weiswald LB, Badoual C, Dangles-Marie V, Mauge L, Evrard S, Laurendeau I, Lallemand F, Germain S, Grelac F, Dizier B, Vidaud M, Bieche I, Gaussem P (2010) The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential. Arterioscler Thromb Vasc Biol (in press)
28. P Foubert JS Silvestre B Souttou V Barateau C Martin TG Ebrahimian C Lere-Dean JO Contreres E Sulpice BI Levy J Plouet G Tobelem S Le Ricousse-Roussanne 2007 PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells J Clin Invest 117 1527 1537 1:CAS:528:DC%2BD2sXmsVWktbc%3D 10.1172/JCI28338 17510705 (Pubitemid 46871337)
29. DM Smadja P Gaussem L Mauge D Israel-Biet F Dignat-George S Peyrard G Agnoletti PR Vouhe D Bonnet M Levy 2009 Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease Circulation 119 374 381 10.1161/CIRCULATIONAHA.108. 808246 19139384
30. PM Hassoun L Mouthon JA Barbera S Eddahibi SC Flores F Grimminger PL Jones ML Maitland ED Michelakis NW Morrell JH Newman M Rabinovitch R Schermuly KR Stenmark NF Voelkel JX Yuan M Humbert 2009 Inflammation, growth factors, and pulmonary vascular remodeling J Am Coll Cardiol 54 S10 S19 1:CAS:528: DC%2BC3cXkvVOks7o%3D 10.1016/j.jacc.2009.04.006 19555853
31. CF Lam TE Peterson AJ Croatt KA Nath ZS Katusic 2005 Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension Am J Physiol Heart Circ Physiol 289 H2334 H2341 1:CAS:528:DC%2BD28XlslGguw%3D%3D 10.1152/ajpheart.00375.2005 15964923 (Pubitemid 41698540)
32. SM Black JR Fineman RH Steinhorn J Bristow SJ Soifer 1998 Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension Am J Physiol 275 H1643 H1651 1:CAS:528:DyaK1cXnsF2htrY%3D 9815072
33. DS Celermajer S Cullen JE Deanfield 1993 Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics Circulation 87 440 446 1:STN:280:DyaK3s7ksFCmtA%3D%3D 8425291 (Pubitemid 23040913)
34. Fadini GP, Avogaro A, Ferraccioli G, Agostini C (2010) Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J 35:418-425
35. S Dussault F Maingrette C Menard SE Michaud P Haddad J Groleau J Turgeon G Perez A Rivard 2009 Sildenafil increases endothelial progenitor cell function and improves ischemia-induced neovascularization in hypercholesterolemic apolipoprotein E-deficient mice Hypertension 54 1043 1049 1:CAS:528: DC%2BD1MXht1ymsr3I 10.1161/HYPERTENSIONAHA.109.139451 19770400
36. M Iglarz JS Silvestre M Duriez D Henrion BI Levy 2001 Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway Arterioscler Thromb Vasc Biol 21 1598 1603 1:CAS:528:DC%2BD3MXnslaqtr8%3D 10.1161/hq1001.097065 11597932 (Pubitemid 34215578)
37. CK Sun FY Lee JJ Sheu CM Yuen S Chua SY Chung HT Chai YT Chen YH Kao LT Chang HK Yip 2009 Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats J Pharmacol Exp Ther 330 718 726 1:CAS:528:DC%2BD1MXhtVyitL%2FP 10.1124/jpet.109.154328 19528354
38. R Di Stefano MC Barsotti E Melillo M Iorio T Santoni C Armani M Dell'omodarme C Ristori R De Caterina A Balbarini 2008 The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia Thromb Haemost 100 871 877 1:CAS:528:DC%2BD1cXhsVGls77O 18989532
39. N Galie HA Ghofrani A Torbicki RJ Barst LJ Rubin D Badesch T Fleming T Parpia G Burgess A Branzi F Grimminger M Kurzyna G Simonneau 2005 Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2148 2157 1:CAS:528:DC%2BD2MXht1ajtb%2FI 10.1056/NEJMoa050010 16291984 (Pubitemid 41653106)
40. N Galie BH Brundage HA Ghofrani RJ Oudiz G Simonneau Z Safdar S Shapiro RJ White M Chan A Beardsworth L Frumkin RJ Barst 2009 Tadalafil therapy for pulmonary arterial hypertension Circulation 119 2894 2903 1:CAS:528: DC%2BD1MXms1alsb0%3D 10.1161/CIRCULATIONAHA.108.839274 19470885
41. G Simonneau LJ Rubin N Galie RJ Barst TR Fleming AE Frost PJ Engel MR Kramer G Burgess L Collings N Cossons O Sitbon DB Badesch 2008 Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial Ann Intern Med 149 521 530 18936500
42. N Galie H Olschewski RJ Oudiz F Torres A Frost HA Ghofrani DB Badesch MD McGoon VV McLaughlin EB Roecker MJ Gerber C Dufton BL Wiens LJ Rubin 2008 Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2 Circulation 117 3010 3019 1:CAS:528:DC%2BD1cXmsFymu70%3D 10.1161/CIRCULATIONAHA.107.742510 18506008
43. RN Channick G Simonneau O Sitbon IM Robbins A Frost VF Tapson DB Badesch S Roux M Rainisio F Bodin LJ Rubin 2001 Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 1119 1123 1:CAS:528:DC%2BD3MXntlOrurs%3D 10.1016/S0140-6736(01)06250-X 11597664 (Pubitemid 32971843)
44. M Humbert RJ Barst IM Robbins RN Channick N Galie A Boonstra LJ Rubin EM Horn A Manes G Simonneau 2004 Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Eur Respir J 24 353 359 1:CAS:528:DC%2BD2cXotlyrtL4%3D 10.1183/09031936.04.00028404 15358690 (Pubitemid 39232254)
45. G Piaggio V Rosti M Corselli F Bertolotti G Bergamaschi S Pozzi D Imperiale B Chiavarina E Bonetti F Novara M Sessarego L Villani A Garuti A Massa R Ghio R Campanelli A Bacigalupo A Pecci G Viarengo O Zuffardi F Frassoni G Barosi 2009 Endothelial colony forming cells (ECFCs) from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker Blood 14 3127 3130 10.1182/blood-2008-12-190991
46. RJ Barst LJ Rubin WA Long MD McGoon S Rich DB Badesch BM Groves VF Tapson RC Bourge BH Brundage, et al. 1996 A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension study group N Engl J Med 334 296 302 1:CAS:528:DyaK28XhsVShs70%3D 10.1056/NEJM199602013340504 8532025 (Pubitemid 26033085)
47. N Galie M Humbert JL Vachiery CD Vizza M Kneussl A Manes O Sitbon A Torbicki M Delcroix R Naeije M Hoeper A Chaouat S Morand B Besse G Simonneau 2002 Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial J Am Coll Cardiol 39 1496 1502 1:CAS:528: DC%2BD38XktVKksbY%3D 10.1016/S0735-1097(02)01786-2 11985913 (Pubitemid 34439066)
48. G Simonneau RJ Barst N Galie R Naeije S Rich RC Bourge A Keogh R Oudiz A Frost SD Blackburn JW Crow LJ Rubin 2002 Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial Am J Respir Crit Care Med 165 800 804 11897647 (Pubitemid 34229650)
49. H Olschewski G Simonneau N Galie T Higenbottam R Naeije LJ Rubin S Nikkho R Speich MM Hoeper J Behr J Winkler O Sitbon W Popov HA Ghofrani A Manes DG Kiely R Ewert A Meyer PA Corris M Delcroix M Gomez-Sanchez H Siedentop W Seeger 2002 Inhaled iloprost for severe pulmonary hypertension N Engl J Med 347 322 329 1:CAS:528:DC%2BD38XlslWqt7c%3D 10.1056/NEJMoa020204 12151469 (Pubitemid 34815354)